Innovative Cybersecurity Solutions Nova Leah specializes in advanced cybersecurity risk management for medical devices, offering automated and traceable solutions like SelectEvidence and the upcoming SelectEvaluate platform, which can enhance the security posture of healthcare providers and device manufacturers.

Market Expansion Opportunities With recent product launches and a growing client base including major health systems like Northwell Health, Nova Leah is positioned for expansion into hospitals, health systems, and medical device companies seeking comprehensive third-party risk management tools.

Strong Funding Backing Having secured seed investment from Northwell Ventures and earlier funding from Kernel Capital and Suir Valley Ventures, Nova Leah demonstrates financial stability and growth potential, making it a promising partner for technology partnerships and joint initiatives.

Growth in Export Potential Receiving the 2019 High Potential Exporter of the Year Award highlights Nova Leah’s international market ambitions, offering opportunities to collaborate with global medical device manufacturers and healthcare providers seeking proven cybersecurity solutions.

Tech Stack Leverage Utilizing a modern tech stack that includes tools like Jira, Bootstrap, and Apache, Nova Leah can integrate seamlessly with existing healthcare IT infrastructures, presenting opportunities to enhance cybersecurity workflows and secure medical data across health networks.